IMRX 10 Year Annualized Return and Average Annual Return

IMRX Average Annual Return Chart Since 2021
Growth of $10,000.00
Without Dividends Reinvested Into IMRX

Also see:
• IMRX stock yearly return 2021
• IMRX stock yearly return 2022
• IMRX stock yearly return 2023
• IMRX stock yearly return 2024
• IMRX stock yearly return 2025
• IMRX YTD return
Average Annual Return Benchmarks
Compare IMRX average annual return versus benchmarks:

S&P Average Annual Return
Dow Average Annual Return
Nasdaq 100 Average Annual Return
Russell 2000 Average Annual Return
Gold Average Annual Return
10 Year Treasury Average Annual Return
IMRX Share Performance
IMRX Average Annual Return Table Since 2021
Start date: 08/02/2021
End date: 07/10/2026
Start price/share: $17.00
End price/share: $5.11
Dividends collected/share: $0.00
Total return: -69.94%
IMRX Average Annual Return: -21.60%
Starting investment: $10,000.00
Ending investment: $3,005.73
Years: 4.94


IMRX average annual return is presented with the assumption of reinvestments of any dividends on ex-date.
About Immuneering Corp
Immuneering Corporation is a clinical-stage oncology company. Co. is engaged in the development of medicines for cancer patients with universal-RAS therapy. Co.'s lead product candidate, IMM-1-104, in under Phase I/IIa clinical trial in patients with advanced solid tumors harboring RAS mutations. IMM-1-104 is being developed as a once-daily oral monotherapy that aims to achieve universal-RAS activity through deep cyclic inhibition of the MAPK pathway. Co.'s second product candidate, IMM-6-415, aims to achieve universal-MAPK activity with an accelerated twice-daily oral dosing cadence, also through deep cyclic inhibition of the MAPK pathway. The IMRX average annual return since 2021 is shown above.

The Average Annual Return on the IMRX average annual return since 2021 page and across the coverage universe of our site, is a measure of the annualized return over the past ten years (or specified start date) for a given investment (up to the end of prior trading session recorded). Arguably, choosing ten years for a measurement period is on the one hand completely arbitrary, but on the other hand provides a sufficiently long window to capture long-term trends.

Thus, researching Average Annual Returns is good practice for investors — whether IMRX average annual return since 2021 or other benchmarks/peers — and when doing so it is also important to factor in dividends, because a financial instrument's annualized return is more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors by performing the IMRX average annual return calculation with any dividends reinvested as applicable (on ex-dates).
IMRX Current Stock Quote
Quotes delayed 20 minutes

Email EnvelopeFree IMRX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
Featured Slideshows
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Don't Forget Dividends in Average Annual Return!
Video: Don't Forget Dividends in Average Annual Return!
Average Annual Return Peers
Immuneering (IMRX) is categorized under the Healthcare sector; to help you further research average annual return performance across stocks, below are some other companies in the same sector:

IMUX Average Annual Return
IMVT Average Annual Return
INAB Average Annual Return
INBS Average Annual Return
INBX Average Annual Return
INCY Average Annual Return
INDP Average Annual Return
INDV Average Annual Return
INGN Average Annual Return
INKT Average Annual Return
More Healthcare companies »
 

IMRX 10 Year Annualized Return & Average Annual Return | www.AverageAnnualReturn.com | Copyright © 2021 - 2026, All Rights Reserved

Nothing in AverageAnnualReturn.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.